Empirical examination of the replicability of associations between brain structure and psychological variables

Abstract

Linking interindividual differences in psychological phenotype to variations in brain structure is an old dream for psychology and a crucial question for cognitive neurosciences. Yet, replicability of the previously-reported 'structural brain behavior' (SBB)-associations has been questioned, recently. Here, we conducted an empirical investigation, assessing replicability of SBB among heathy adults. For a wide range of psychological measures, the replicability of associations with gray matter volume was assessed. Our results revealed that among healthy individuals 1) finding an association between performance at standard psychological tests and brain morphology is relatively unlikely 2) significant associations, found using an exploratory approach, have overestimated effect sizes and 3) can hardly be replicated in an independent sample. After considering factors such as sample size and comparing our findings with more replicable SBB-associations in a clinical cohort and replicable associations between brain structure and non-psychological phenotype, we discuss the potential causes and consequences of these findings.

Data availability

All data used in this study, are openly available (eNKI, ADNI). The eNKI Rockland cohort data were downloaded from http://fcon_1000.projects.nitrc.org/indi/enhanced/. Users are first required to complete a Data Usage Agreement document before access to these data is granted (further details here http://fcon_1000.projects.nitrc.org/indi/enhanced/phenotypicdata.html). The ADNI data were downloaded from http://adni.loni.usc.edu/about/. Users must first request access before they can log in to the data archive and access is contingent on adherence to the ADNI Data Use Agreement (further details here http://adni.loni.usc.edu/data-samples/access-data/).

Article and author information

Author details

  1. Shahrzad Kharabian Masouleh

    Institute of Neuroscience and Medicine (INM-7: Brain and Behaviour), Research Centre Jülich, Jülich, Germany
    For correspondence
    s.kharabian@fz-juelich.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4810-9542
  2. Simon B Eickhoff

    Institute of Neuroscience and Medicine (INM-7: Brain and Behaviour), Research Centre Jülich, Jülich, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6363-2759
  3. Felix Hoffstaedter

    Institute of Neuroscience and Medicine (INM-7: Brain and Behaviour), Research Centre Jülich, Jülich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Sarah Genon

    Institute of Neuroscience and Medicine (INM-7: Brain and Behaviour), Research Centre Jülich, Jülich, Germany
    For correspondence
    s.genon@fz-juelich.de
    Competing interests
    The authors declare that no competing interests exist.
  5. Alzheimer’s Disease Neuroimaging Initiative

Funding

Deutsche Forschungsgemeinschaft

  • Shahrzad Kharabian Masouleh
  • Sarah Genon

Helmholtz-Gemeinschaft

  • Shahrzad Kharabian Masouleh
  • Simon B Eickhoff
  • Felix Hoffstaedter
  • Sarah Genon

Horizon 2020 Framework Programme

  • Shahrzad Kharabian Masouleh
  • Simon B Eickhoff
  • Felix Hoffstaedter
  • Sarah Genon

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Thomas E Nichols, University of Oxford, United Kingdom

Ethics

Human subjects: Institutional Review Board Approval (IRBA) was obtained for this project at the Nathan Kline Institute (Phase I #226781 and Phase II #239708) and at Montclair State University (Phase I #000983A and Phase II #000983B). Written informed consent was obtained for all study participants.For ADNI data, IRBA was also obtained within each participating institute as well as informed consent forms were signed by each participant (see https://adni.loni.usc.edu/wp-content/uploads/2017/09/ADNID_Approved_Protocol_11.19.14.pdf for detailed information about ethical procedures for ADNI).Additionally, analysis of the data from both eNKI (Study No. 4039) and ADNI (Registration No. 2018114856) received ethical approval from the ethics committee of medical faculty at the University of Düsseldorf.

Version history

  1. Received: November 7, 2018
  2. Accepted: March 8, 2019
  3. Accepted Manuscript published: March 13, 2019 (version 1)
  4. Version of Record published: April 25, 2019 (version 2)

Copyright

© 2019, Kharabian Masouleh et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,327
    views
  • 728
    downloads
  • 113
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Shahrzad Kharabian Masouleh
  2. Simon B Eickhoff
  3. Felix Hoffstaedter
  4. Sarah Genon
  5. Alzheimer’s Disease Neuroimaging Initiative
(2019)
Empirical examination of the replicability of associations between brain structure and psychological variables
eLife 8:e43464.
https://doi.org/10.7554/eLife.43464

Share this article

https://doi.org/10.7554/eLife.43464

Further reading

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Katarzyna Marta Zoltowska, Utpal Das ... Lucía Chávez-Gutiérrez
    Research Article

    Amyloid β (Aβ) peptides accumulating in the brain are proposed to trigger Alzheimer’s disease (AD). However, molecular cascades underlying their toxicity are poorly defined. Here, we explored a novel hypothesis for Aβ42 toxicity that arises from its proven affinity for γ-secretases. We hypothesized that the reported increases in Aβ42, particularly in the endolysosomal compartment, promote the establishment of a product feedback inhibitory mechanism on γ-secretases, and thereby impair downstream signaling events. We conducted kinetic analyses of γ-secretase activity in cell-free systems in the presence of Aβ, as well as cell-based and ex vivo assays in neuronal cell lines, neurons, and brain synaptosomes to assess the impact of Aβ on γ-secretases. We show that human Aβ42 peptides, but neither murine Aβ42 nor human Aβ17–42 (p3), inhibit γ-secretases and trigger accumulation of unprocessed substrates in neurons, including C-terminal fragments (CTFs) of APP, p75, and pan-cadherin. Moreover, Aβ42 treatment dysregulated cellular homeostasis, as shown by the induction of p75-dependent neuronal death in two distinct cellular systems. Our findings raise the possibility that pathological elevations in Aβ42 contribute to cellular toxicity via the γ-secretase inhibition, and provide a novel conceptual framework to address Aβ toxicity in the context of γ-secretase-dependent homeostatic signaling.

    1. Computational and Systems Biology
    2. Neuroscience
    Sara Ibañez, Nilapratim Sengupta ... Christina M Weaver
    Research Article

    Normal aging leads to myelin alterations in the rhesus monkey dorsolateral prefrontal cortex (dlPFC), which are positively correlated with degree of cognitive impairment. It is hypothesized that remyelination with shorter and thinner myelin sheaths partially compensates for myelin degradation, but computational modeling has not yet explored these two phenomena together systematically. Here, we used a two-pronged modeling approach to determine how age-related myelin changes affect a core cognitive function: spatial working memory. First, we built a multicompartment pyramidal neuron model fit to monkey dlPFC empirical data, with an axon including myelinated segments having paranodes, juxtaparanodes, internodes, and tight junctions. This model was used to quantify conduction velocity (CV) changes and action potential (AP) failures after demyelination and subsequent remyelination. Next, we incorporated the single neuron results into a spiking neural network model of working memory. While complete remyelination nearly recovered axonal transmission and network function to unperturbed levels, our models predict that biologically plausible levels of myelin dystrophy, if uncompensated by other factors, can account for substantial working memory impairment with aging. The present computational study unites empirical data from ultrastructure up to behavior during normal aging, and has broader implications for many demyelinating conditions, such as multiple sclerosis or schizophrenia.